Dutasteride is a daily capsule that blocks both enzymes your body uses to turn testosterone into DHT, the hormone behind male pattern hair loss.[1] In a trial that randomized 917 men, dutasteride 0.5 mg grew more hair than finasteride 1 mg after 24 weeks.[1] The trade-offs: it lingers in your body for months[2], and its hair loss approvals are in South Korea and Japan, not the United States.[3]
Hair Library · Hair Loss Treatments
Dutasteride for Hair Loss: How It Works and How It Compares With Finasteride
How dutasteride blocks both enzymes that make DHT, how it compares with finasteride in head-to-head trials, its side effects, and the checks the label asks for before you start.

Written by Nazmi Güldeş, Certified Trichologist · Medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi), Plastic, Reconstructive and Aesthetic Surgeon · Last reviewed 30 October 2026
Reading levelWhat Is Dutasteride?
Dutasteride is a prescription 0.5 mg capsule that blocks both type 1 and type 2 5-alpha reductase, the enzymes that make DHT. Blood DHT falls by about 90% within two weeks.[2] It is approved for male pattern hair loss in South Korea and Japan; in the United States it is approved only for an enlarged prostate.[3][2]
It was first approved in the United States in 2001 as Avodart, for benign prostatic hyperplasia.[2] Its use for hair rests on trials showing that blocking both enzymes grows more scalp hair than blocking type 2 alone.[4][1]
It is a medicine for men. Pregnant women must not take it, and women who are or may be pregnant should not even handle the capsules.[2]
Dutasteride vs Finasteride
How Dutasteride Lowers DHT
Your body makes DHTGlossaryDihydrotestosterone (DHT) is a potent androgen that the body makes from testosterone using an enzyme called 5-alpha reductase. In people who are genetically sensitive to it, DHT makes hair follicles shrink.
Open in the glossary → with 5-alpha reductase, which comes in two forms. Type 2 works mainly in reproductive tissues, while type 1 also works in the skin and liver.[2] Finasteride blocks type 2 only; dutasteride blocks both.[1]
In men treated for an enlarged prostate, median blood DHT stayed 93% to 95% lower for four years.[2] Why DHT thins some follicles and spares others, and how every DHT treatment compares, is covered in our entry on DHT and hair loss.
Dutasteride vs Finasteride: Head-to-Head Results
In the main head-to-head trial, 917 men aged 20 to 50 took dutasteride, finasteride or placebo for 24 weeks.[1]
| Dutasteride 0.5 mg | Finasteride 1 mg | |
|---|---|---|
| Enzymes blocked | Type 1 and type 2[1] | Type 2 only[1] |
| Half-life | About 5 weeks[3] | About 4.5 hours[3] |
| Approved for hair loss | Men, in South Korea and Japan[3] | Men, approved by the FDA[3] |
| Hair count at 24 weeks, 917 men | Significantly more hair[1] | Less than dutasteride[1] |
| Network meta-analysis | 7.1 more hairs per cm² at 24 weeks[5] | Largest gain in terminal (thick) hairs at 48 weeks[5] |
| Sexual side effects against placebo | Relative risk 1.37, not significant[6] | Relative risk 1.66[6] |
| Effect on PSA | About 50% lower[2] | 40% to 50% lower in men aged 40 to 60[7] |
Not every trial agrees. A 2017 trial of 90 men found more new hair and fewer thin, miniaturized hairs on dutasteride[8], and a meta-analysis of 576 men favoured it on hair counts and photographs.[9] A 2026 trial of 46 men with moderate to severe loss found no significant difference after 24 weeks.[10] Weighing 33 studies, a 2025 network meta-analysis still ranked dutasteride 0.5 mg first.[11]
Dutasteride Results, Side Effects and Mesotherapy
Dutasteride Results Timeline
Dutasteride builds up slowly: blood levels reach 65% of their steady state after one month and about 90% after three.[2]
| Time on dutasteride | What the trials and label show |
|---|---|
| Weeks 1 to 2 | Blood DHT is 85% lower after one week and 90% lower after two[2] |
| Week 12 | In a 416-man trial, 2.5 mg already beat finasteride 5 mg[4] |
| Week 24 | Hair count rose by 12.2 per cm², against 4.7 on placebo, in a trial of 153 men[12] |
| Week 52 | Hair count, hair width and overall appearance had improved in 120 Japanese men[13] |
| Year 5 | 89.9% of 99 Korean men were rated improved[14] |
| After stopping | Dutasteride stays measurable in the blood for 4 to 6 months[2] |
Improvement in pattern hair loss typically takes at least six months, so judge it no earlier.[15]
Dutasteride Dosage: 0.5 mg and Lower
The standard dose is one 0.5 mg capsule a day, swallowed whole, because the contents can irritate your mouth and throat.[2] A lower dose may be enough: in a 2025 trial of 139 men, 0.2 mg matched 0.5 mg on every efficacy measure at 24 weeks.[16]
Dutasteride Side Effects
In the prostate trials, in men aged 47 to 94, these were the rates in the first six months:[2]
- Erection problems: 4.7% on dutasteride, 1.7% on placebo
- Lower sex drive: 3.0% against 1.4%
- Ejaculation problems: 1.4% against 0.5%
- Breast tenderness or enlargement: 0.5% against 0.2%
Sexual side effects may continue after stopping; the label says the role of dutasteride in this is unknown.[2]
Hair-loss trials in younger men give a mixed picture. In one 117-man trial, sexual side effects affected 16% on dutasteride and 8% on placebo, all mild to moderate and reversible.[17] A 2026 review put the range at 4.1% to 12.0% on dutasteride, against 4.0% to 5.0% on placebo.[18] Yet the 2019 meta-analysis found no significant rise and called the dutasteride data limited.[6]
Depressed mood is listed among reports received since approval.[2] If your mood drops, tell your doctor; persistent symptoms are covered in our entry on post-finasteride syndrome.
Sperm changes too. After a year, total sperm count was 23% lower and still 23% down 24 weeks after stopping, while the effect on fertility is unknown.[2] If you are trying for a baby, raise it with your doctor.
Dutasteride Mesotherapy and Topical Use
Mesotherapy means injecting a dilute dutasteride solution into the scalp skin, where very little reaches the bloodstream. It is off-label and has no FDA approval.[19]
A 2025 systematic review found denser, thicker hair with few side effects, but small and varied studies.[20] A 2025 network meta-analysis found injections significantly less effective than the capsule.[11] In one series of 15 patients, 4 developed patchy hair loss at the injection sites after a single session[19], and in three women in another report the patches never fully regrew.[21]
Microneedling followed by a dutasteride solution is another local route; both methods still lack standard protocols and large trials.[22]
Before You Start Dutasteride
Is Dutasteride FDA Approved for Hair Loss?
No. In the United States it is approved for an enlarged prostate, and doctors prescribe it for hair off-label.[2][3] Elsewhere:
- South Korea approved it for male pattern hair loss in 2009.[14]
- Japan has approved it for men[3], and its guideline lists it as a first-line treatment.[23]
- Canada: a 2025 expert panel recommends oral dutasteride, while giving scalp injections only near-consensus support.[24]
Blood Donation, Pregnancy and PSA Tests
The label sets out checks that apply whatever the reason you take it:[2]
- Blood donation. Wait at least 6 months after your last dose, so a pregnant woman cannot receive dutasteride through a transfusion.[2]
- Pregnancy. Women who are or may be pregnant should not handle the capsules, because dutasteride passes through skin and could put a male baby at risk. Wash any contact with a leaking capsule with soap and water.[2]
- PSA tests. PSA falls by about 50% within 3 to 6 months, so after three months a single reading is doubled before comparing it with normal values.[2]
- Any rise. A confirmed rise from your lowest PSA needs checking, even inside the normal range. Tell whoever orders the test that you take dutasteride.[2]

Dutasteride for Women
Dutasteride is not indicated for women.[2] The Japanese guideline says it is contraindicated for female pattern hair loss[23], though some dermatologists use it off-label.[25]
In frontal fibrosing alopecia, a scarring hair loss, a meta-analysis of 366 patients found it stabilized the disease in about 63%.[26] For pattern thinning, read about female pattern hair loss and spironolactone.
Dutasteride and a Hair Transplant
A transplant moves follicles from the donor areaGlossaryThe donor area is the back and sides of the head, where follicles resist DHT. An extracted follicle does not grow back in that spot, so extractions are spread out, and the donor supply is the limit of every plan.
Open in the glossary → to thinning zones, but the native hair around the grafts can keep miniaturizing and erode the result.[27]
The surgical trial evidence comes from finasteride: taken from four weeks before to 48 weeks after surgery, it improved hair around the grafts in 79 men.[27] We found no matching trial for dutasteride, so the logic holds but the proof is thinner. See our finasteride entry and our guide to preparing for a hair transplant.
Because surgery cannot stop native hair from thinning[27], it is the wrong first answer when most of your loss is still thinning hair rather than bare scalp. Start with medication and judge it after six months or more.[15]
Frequently Asked Questions
Can you switch from finasteride to dutasteride?
Can dutasteride regrow a receding hairline?
Does dutasteride cause shedding?
Open in the glossary → may be involved.
Does dutasteride lower testosterone?
Can dutasteride cause depression?
Can women take dutasteride?
Can you take dutasteride and minoxidil together?
Does dutasteride cause prostate cancer?
Is Dutasteride Right for You?
Dutasteride suits men with pattern hair loss who want more DHT suppression than finasteride gives, or who did not respond to it, and who accept a drug that lingers for months.[3][28][2] It is not an option for women who could become pregnant.[2]
If you are weighing dutasteride against finasteride, or a transplant as well, send us three photos for a free hair analysis. The medical team will tell you whether your pattern of loss suits medication, surgery or both. You can also message us on WhatsApp.
About the Author
Written by: Nazmi Güldeş, Certified Trichologist. Nazmi Güldeş focuses on patient education around androgenetic alopecia, evaluating miniaturization through dermoscopy, and assessing candidates for medical treatments and hair transplants.
Editorial Policy & Trust
This entry was drafted with the help of AI writing tools and edited by our team, then medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi) on 30 October 2026. AI is never used as a source: every study cited here was checked against PubMed on 30 October 2026, and each claim sits next to the study that supports it. Read how we work in our editorial policy.
Test yourself
Check what you remember from this entry. Each answer links back to the section that explains it.
- How long should you wait to donate blood after your last dutasteride capsule?
The label asks for at least 6 months, so a pregnant woman cannot receive dutasteride through a transfusion. Read the section
- In the 917-man trial, how did dutasteride 0.5 mg compare with finasteride 1 mg at 24 weeks?
Hair count was significantly higher on dutasteride, with a similar number of side effects. Read the section
- How did dutasteride injections (mesotherapy) rank against the capsule in a 2025 network meta-analysis?
Mesotherapy was significantly less effective than the 0.5 mg capsule. Read the section
Evidence behind this entry: 28 publications indexed in PubMed (2005 to 2026): 9 randomized trials, 8 systematic reviews, 4 reviews, 2 clinical studies, 2 case reports, 2 guidelines and 1 clinical trial. Plus the FDA prescribing information for Avodart (dutasteride 0.5 mg). 9 sources have free full text.
- Randomized trialpeople assigned to treatments by chance
- Reviewsummarises many studies
- Clinical studya study in people without random groups
- Guideline or labela professional body, or the official drug label
Every source checked against PubMed on 30 October 2026, including corrections and retractions. See the newest studies on PubMed →
References
- Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. 2014;70(3):489-498.e3.Randomized trialPubMedDOI
- U.S. Food and Drug Administration. AVODART (dutasteride) soft gelatin capsules: prescribing information. Revised January 2020.Drug labelSource page
- Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. The Journal of Dermatological Treatment. 2022;33(7):2946-2962.ReviewPubMedDOI
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023.Randomized trialPubMedDOI
- Gupta AK, Venkataraman M, Talukder M, et al. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatology. 2022;158(3):266-274.Systematic reviewPubMedDOIFree full text
- Lee S, Lee YB, Choe SJ, et al. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 2019;99(1):12-17.Systematic reviewPubMedDOI
- D'Amico AV, Roehrborn CG. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. The Lancet Oncology. 2007;8(1):21-25.Randomized trialPubMedDOI
- Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Indian Journal of Dermatology, Venereology and Leprology. 2017;83(1):47-54.Randomized trialPubMedDOI
- Zhou Z, Song S, Gao Z, et al. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging. 2019;14:399-406.Systematic reviewPubMedDOIFree full text
- Poostiyan N, Nikyar Z, Makhmali R, et al. Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran. The Journal of Dermatological Treatment. 2026;37(1):2583849.Randomized trialPubMedDOI
- Gupta AK, Bamimore MA, Williams G, et al. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. Journal of Cosmetic Dermatology. 2025;24(7):e70320.Systematic reviewPubMedDOIFree full text
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology. 2010;63(2):252-258.Randomized trialPubMedDOI
- Tsunemi Y, Irisawa R, Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology. 2016;43(9):1051-1058.Clinical trialPubMedDOI
- Choi S, Kwon SH, Sim WY, et al. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. The Journal of Dermatology. 2024;51(5):684-690.Clinical studyPubMedDOI
- Iyengar L, Li J. Male and female pattern hair loss. Australian Prescriber. 2025;48(3):93-97.ReviewPubMedDOIFree full text
- Lee S, Kim JE, Lew BL, et al. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. Annals of Dermatology. 2025;37(4):183-190.Randomized trialPubMedDOIFree full text
- Tsai TF, Choi GS, Kim BJ, et al. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia. The Journal of Dermatology. 2018;45(7):799-804.Randomized trialPubMedDOIFree full text
- Złotowska A, Jastrząb-Miśkiewicz B, Krajewski PK. Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. Frontiers in Medicine. 2026;13:1787706.Systematic reviewPubMedDOIFree full text
- Chandrashekhar M, Chandrashekar BS, Madura C, et al. Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series. International Journal of Trichology. 2025;17(3):209-214.Case reportPubMedDOIFree full text
- Almeziny A, Alghamdi A, Alajlan A, et al. Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta-Analysis. Journal of Cosmetic Dermatology. 2025;24(12):e70560.Systematic reviewPubMedDOIFree full text
- Nogueira CM, Osório F. Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series. Journal of Drugs in Dermatology. 2026;25(3):951-955.Case reportPubMedDOI
- Ding Y, Wang C, Bi L, et al. Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology (Basel, Switzerland). 2024;240(5-6):833-843.ReviewPubMedDOI
- Manabe M, Tsuboi R, Itami S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology. 2018;45(9):1031-1043.GuidelinePubMedDOI
- Landells I, Chow E, Gupta AK, et al. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. Journal of Cutaneous Medicine and Surgery. 2025;29(5_suppl):5S-14S.GuidelinePubMedDOI
- Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. American Journal of Clinical Dermatology. 2026;27(2):363-389.ReviewPubMedDOI
- Seo HM, Oh SU, Kim S, et al. Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2024;38(8):1514-1521.Systematic reviewPubMedDOI
- Leavitt M, Perez-Meza D, Rao NA, et al. Effects of finasteride (1 mg) on hair transplant. Dermatologic Surgery. 2005;31(10):1268-1276, discussion 1276.Randomized trialPubMedDOI
- Jung JY, Yeon JH, Choi JW, et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. International Journal of Dermatology. 2014;53(11):1351-1357.Clinical studyPubMedDOI
- Uleri A, Nicolas Cornu J, Gobbo A, et al. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis. European Urology Focus. 2024;10(5):751-753.Systematic reviewPubMedDOI
Güldeş, N. (2026, October 30). Dutasteride for hair loss: How it works and how it compares with finasteride. Turkey Hair Center Hair Library. https://turkeyhaircenter.com/dutasteride/
@misc{guldes2026dutasteride,
author = {Güldeş, Nazmi},
title = {Dutasteride for hair loss: How it works and how it compares with finasteride},
howpublished = {Turkey Hair Center Hair Library},
year = {2026},
month = oct,
url = {https://turkeyhaircenter.com/dutasteride/},
note = {Last updated 30 October 2026}
}TY - ELEC AU - Güldeş, Nazmi TI - Dutasteride for hair loss: How it works and how it compares with finasteride T2 - Turkey Hair Center Hair Library PY - 2026 DA - 2026/10/30 UR - https://turkeyhaircenter.com/dutasteride/ N1 - Last updated 30 October 2026 ER -
Ask the Medical Team
About Your Case
Send three photos: front, top and sides. You get a technique recommendation, a graft range and a straight answer about what is achievable, before anyone talks about price.
Your details are with the team
A patient coordinator will get back to you shortly. If you would like to send your photos now, WhatsApp is the fastest way to do it.
Real PeopleReal Support
- Send your photos on WhatsApp
Front, top and both sides, reviewed by the medical team.
Chat now - Call us directly
Speak to a patient coordinator on the phone.
+90 545 249 91 04 - 24/7 patient support
We respond quickly, day or night, in your language.
Multilingual team, no obligation
Explore the Hair Library
78 entries, 46 glossary terms and every source linked to PubMed. Pick a topic and keep reading.
Turkey Hair Center is the hair-restoration brand of Healthy Way Tourism, an authorized international health-tourism intermediary.
All medical procedures are performed by licensed medical professionals at authorized healthcare facilities in Turkiye, in accordance with the regulations of the Ministry of Health.